(R)-4-Methylisoxazolidin-4-ol hydrochloride, 97%, 100mg

4-Fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol, 95.0%, 1g

(E)-2-(4-METHOXYBENZYLIDENEAMINO)-1-PHENYLETHANOL, 95.0%, 1g

2-Methylbenzo[d]isothiazol-3(2H)-one 1,1-dioxide, 95.0%, 1g

2-Chloro-N,N-dimethylacetamide, 97.0%, 1g

HPLC cap GL 45 Connections with stopcocks, 3, 1.6 mm, 1 Piece

4-Bromo-3-methyl-isothiazol-5-ylamine, 95.0%, 250mg

Lithium bromide, min. 99%, anhydrous, 500 g, plastic packaging.

2-Chloro-1-(2,3-dihydro-indol-1-yl)-ethanone, 95.0%, 25g

3-Tetrazol-1-yl-benzoic acid, 95.0%, 100g

6-Chloro-4-(cyclopropylamino)nicotinaldehyde, 250mg

5-amino-2-methoxybenzoic acid, 95.0%, 100g

(S)-tert-Butyl 2-(2-hydroxyethyl)azetidine-1-carboxylate, 98%, 1g